These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23871340)

  • 1. Ticagrelor or prasugrel for pre-hospital protocols in STEMI?
    Fournier N; Toesca R; Bessereau J; Champenois A; Mazille A; Luigi S; Yvorra S; Paganelli F; Brun PM; Michelet P; Meyran D; Auffray JP; Bonello L
    Int J Cardiol; 2013 Oct; 168(4):4566-7. PubMed ID: 23871340
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.
    Alexopoulos D; Xanthopoulou I; Gkizas V; Kassimis G; Theodoropoulos KC; Makris G; Koutsogiannis N; Damelou A; Tsigkas G; Davlouros P; Hahalis G
    Circ Cardiovasc Interv; 2012 Dec; 5(6):797-804. PubMed ID: 23169985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study.
    Parodi G; Bellandi B; Valenti R; Migliorini A; Marcucci R; Carrabba N; Giurlani L; Gensini GF; Abbate R; Antoniucci D
    Am Heart J; 2014 Jun; 167(6):909-14. PubMed ID: 24890542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in acute cardiovascular care.
    Taylor J
    Eur Heart J; 2014 Mar; 35(9):535. PubMed ID: 24730030
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor.
    Orban M; Riegger J; Joner M; Tada T; Okrojek R; Hausleiter J; Kastrati A; Massberg S; Sibbing D
    Platelets; 2012; 23(5):395-8. PubMed ID: 22671583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor effectiveness overestimated by VASP index: platelet inhibition by ticagrelor versus prasugrel in acute coronary syndrome patients according to platelet function tests.
    Dillinger JG; Manzo Silberman S; Bal dit Sollier C; Amsallem M; Sideris G; Voicu S; Henry P; Drouet L
    Int J Cardiol; 2014 Sep; 176(2):557-9. PubMed ID: 25074556
    [No Abstract]   [Full Text] [Related]  

  • 7. Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes.
    Serebruany VL; DiNicolantonio JJ
    Thromb Haemost; 2013 Jul; 110(1):5-10. PubMed ID: 23743577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal antiplatelet and antithrombotic therapy in patients with ST elevation myocardial infarction].
    Koziński M; Grześk G; Kubica J
    Kardiol Pol; 2012; 70(2):206-12. PubMed ID: 22427098
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to letter regarding article, "Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction".
    Alexopoulos D; Xanthopoulou I; Gkizas V; Kassimis G; Theodoropoulos K; Makris G; Koutsogiannis N; Damelou A; Tsigkas G; Davlouros P; Hahalis G
    Circ Cardiovasc Interv; 2013 Apr; 6(2):e29. PubMed ID: 23591428
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter by Grove and Kristensen regarding article, "Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction".
    Grove EL; Kristensen SD
    Circ Cardiovasc Interv; 2013 Apr; 6(2):e28. PubMed ID: 23591427
    [No Abstract]   [Full Text] [Related]  

  • 11. Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome.
    Torngren K; Ohman J; Salmi H; Larsson J; Erlinge D
    Cardiology; 2013; 124(4):252-8. PubMed ID: 23594617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: Ready for prime time?
    Alexopoulos D; Moulias A; Kanakakis I; Xanthopoulou I
    Int J Cardiol; 2015 Sep; 194():41-3. PubMed ID: 26011263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome.
    Piccolo R; Di Gioia G; Niglio T; D'Anna C; De Rosa R; Strisciuglio T; Bevilacqua M; Piscione F; Cirillo P; Galasso G
    Angiology; 2014 Feb; 65(2):130-6. PubMed ID: 23221279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving pattern of on-prasugrel and on-ticagrelor platelet reactivity over time in ST elevation myocardial infarction patients.
    Alexopoulos D; Xanthopoulou I; Siapika A; Tsoni E; Stavrou K; Theodoropoulos KC; Davlouros P
    Int J Cardiol; 2013 Sep; 168(1):629-30. PubMed ID: 23434008
    [No Abstract]   [Full Text] [Related]  

  • 15. A brief review of the past and future of platelet P2Y12 antagonist.
    Barn K; Steinhubl SR
    Coron Artery Dis; 2012 Sep; 23(6):368-74. PubMed ID: 22735090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Capranzano P; Mehran R; Tamburino C; Stone GW; Dangas G
    Hosp Pract (1995); 2010 Nov; 38(4):38-43. PubMed ID: 21068525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to manage prasugrel and ticagrelor in daily practice.
    Bonhomme F; Fontana P; Reny JL
    Eur J Intern Med; 2014 Mar; 25(3):213-20. PubMed ID: 24529662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study.
    Alexopoulos D; Galati A; Xanthopoulou I; Mavronasiou E; Kassimis G; Theodoropoulos KC; Makris G; Damelou A; Tsigkas G; Hahalis G; Davlouros P
    J Am Coll Cardiol; 2012 Jul; 60(3):193-9. PubMed ID: 22789884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient?
    Kern MJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):255-62. PubMed ID: 22271555
    [No Abstract]   [Full Text] [Related]  

  • 20. ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.
    Oprea AD; Popescu WM
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):779-95. PubMed ID: 23648080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.